Integer Holdings Co. (NYSE:ITGR) Forecasted to Post Q1 2024 Earnings of $1.11 Per Share

Integer Holdings Co. (NYSE:ITGR - Free Report) - Investment analysts at Zacks Research cut their Q1 2024 earnings per share estimates for Integer in a research note issued on Thursday, April 18th. Zacks Research analyst D. Dey now anticipates that the medical equipment provider will post earnings per share of $1.11 for the quarter, down from their previous estimate of $1.14. The consensus estimate for Integer's current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Integer's Q3 2024 earnings at $1.40 EPS, Q4 2024 earnings at $1.52 EPS, FY2024 earnings at $5.25 EPS, Q3 2025 earnings at $1.58 EPS, FY2025 earnings at $6.08 EPS and FY2026 earnings at $6.51 EPS.

A number of other research firms have also weighed in on ITGR. Benchmark boosted their price objective on Integer from $105.00 to $130.00 and gave the stock a "buy" rating in a research note on Thursday, March 28th. Bank of America raised Integer from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $105.00 to $135.00 in a research note on Monday. CL King initiated coverage on Integer in a research note on Thursday, March 14th. They set a "buy" rating and a $137.00 price objective on the stock. Finally, KeyCorp boosted their price objective on Integer from $123.00 to $139.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 9th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $120.50.

Integer Price Performance

Shares of NYSE:ITGR traded down $1.25 during trading on Friday, reaching $116.58. The stock had a trading volume of 450,401 shares, compared to its average volume of 315,025. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.71 and a current ratio of 2.80. The business has a fifty day moving average price of $111.82 and a 200-day moving average price of $98.49. The stock has a market cap of $3.91 billion, a PE ratio of 43.34, a PEG ratio of 1.64 and a beta of 1.10. Integer has a 1-year low of $69.40 and a 1-year high of $121.53.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.05. The firm had revenue of $413.15 million for the quarter, compared to analyst estimates of $409.04 million. Integer had a return on equity of 10.80% and a net margin of 5.68%. The business's revenue was up 10.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.11 earnings per share.

Hedge Funds Weigh In On Integer

Several large investors have recently modified their holdings of the business. Covestor Ltd raised its holdings in shares of Integer by 420.6% in the 1st quarter. Covestor Ltd now owns 328 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 265 shares during the period. Blue Trust Inc. raised its holdings in shares of Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider's stock valued at $45,000 after buying an additional 377 shares during the period. State of Wyoming raised its holdings in shares of Integer by 129.5% in the 4th quarter. State of Wyoming now owns 840 shares of the medical equipment provider's stock valued at $58,000 after buying an additional 474 shares during the period. Tower Research Capital LLC TRC raised its holdings in shares of Integer by 28.5% in the 1st quarter. Tower Research Capital LLC TRC now owns 775 shares of the medical equipment provider's stock valued at $60,000 after buying an additional 172 shares during the period. Finally, Principal Securities Inc. purchased a new stake in shares of Integer in the 4th quarter valued at $67,000. Institutional investors and hedge funds own 99.29% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.